Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expanding access to genetic testing for pancreatic cancer.

Familial cancer - 1 Aug 2024

Rodriguez Nicolette Juliana, Syngal Sapna

Abstract excerpt

Among individuals with pancreatic ductal adenocarcinoma (PDAC) 5-10% have a pathogenic germline variant (PGV) in a PDAC susceptibility gene. Guidelines recommend genetic testing among all individuals with PDAC. Additionally, at-risk relatives of PDAC patients benefit from their own genetic education, risk assessment, and testing. Multigene panel testing (MGPT) can identify individuals with inherited cancer risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Genetic Counseling
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Health Services Accessibility

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38733419
DOI: 10.1007/s10689-024-00389-w
PMCID: PMC11532997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expanding access to genetic testing for pancreatic cancer.PMID 38733419Read ↗

Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.Semantic proximity Read ↗

Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.Semantic proximity Read ↗

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.Semantic proximity Read ↗

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.Semantic proximity Read ↗

Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.Semantic proximity Read ↗

Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic AdenocarcinomaSemantic proximity Read ↗

Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.Semantic proximity Read ↗

Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families.Semantic proximity Read ↗

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.Semantic proximity Read ↗

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.Semantic proximity Read ↗

Evaluating Implementation of NCCN Guideline-Directed Genetic Screening Recommendations for Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.